Stock INDRANIB6 INDRAYANI BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Indrayani Biotech Limited

Equities

INDRANIB6

INE007C01021

Hotels, Motels & Cruise Lines

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-05-14 am EDT 		5-day change 1st Jan Change
51.51 INR +0.06% Intraday chart for Indrayani Biotech Limited -2.00% -18.46%
Feb. 10 Indrayani Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Jan. 10 Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes CI

Valuation

Fiscal Period: March 2020 2021 2022 2023
Capitalization 1 30.43 217.3 1,044 1,934
Enterprise Value (EV) 1 153.8 365.9 1,217 2,509
P/E ratio 3.76 x -1.15 x 23.5 x 27.6 x
Yield - - - -
Capitalization / Revenue 0.06 x 1.03 x 1.7 x 1.19 x
EV / Revenue 0.31 x 1.74 x 1.98 x 1.54 x
EV / EBITDA 5.54 x -7.39 x 18.4 x 14.7 x
EV / FCF - - -38,956,100 x -7,673,099 x
FCF Yield - - -0% -0%
Price to Book 0.1 x 1.1 x 4.32 x 4.22 x
Nbr of stocks (in thousands) 3,644 34,227 34,227 34,227
Reference price 2 8.350 6.350 30.50 56.51
Announcement Date 9/7/21 9/7/21 9/7/22 8/29/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 499 210.9 615.8 1,629
EBITDA 1 27.76 -49.53 66.28 171.2
EBIT 1 17.61 -54.11 62.17 144
Operating Margin 3.53% -25.66% 10.1% 8.84%
Earnings before Tax (EBT) 1 8.073 -112.1 44.4 123.1
Net income 1 8.073 -112.1 44.4 87.37
Net margin 1.62% -53.18% 7.21% 5.36%
EPS 2 2.220 -5.520 1.300 2.050
Free Cash Flow - - -31.24 -327
FCF margin - - -5.07% -20.07%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 9/7/21 9/7/21 9/7/22 8/29/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 123 149 173 575
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 4.446 x -3 x 2.609 x 3.357 x
Free Cash Flow - - -31.2 -327
ROE (net income / shareholders' equity) - -44% 19.9% 32.7%
ROA (Net income/ Total Assets) - -7.39% 8.5% 8.68%
Assets 1 - 1,518 522.4 1,006
Book Value Per Share 2 84.80 5.760 7.060 13.40
Cash Flow per Share 2 3.860 0.2000 0.4400 0.8900
Capex - - 11.9 239
Capex / Sales - - 1.93% 14.66%
Announcement Date 9/7/21 9/7/21 9/7/22 8/29/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Hotels & Motels

1st Jan change Capi.
INDRAYANI BIOTECH LIMITED Stock Indrayani Biotech Limited
-18.46% 28.07M
H WORLD GROUP LIMITED Stock H World Group Limited
+23.47% 12.77B
WHITBREAD PLC Stock Whitbread PLC
-14.82% 7.13B
WYNDHAM HOTELS & RESORTS, INC. Stock Wyndham Hotels & Resorts, Inc.
-11.93% 5.71B
CHOICE HOTELS INTERNATIONAL, INC. Stock Choice Hotels International, Inc.
+4.44% 5.62B
SHANGHAI JIN JIANG INTERNATIONAL HOTELS CO., LTD. Stock Shanghai Jin Jiang International Hotels Co., Ltd.
-2.78% 3.92B
SHANGRI-LA ASIA LIMITED Stock Shangri-La Asia Limited
+11.94% 2.69B
ATOUR LIFESTYLE HOLDINGS LIMITED Stock Atour Lifestyle Holdings Limited
+4.32% 2.5B
BTG HOTELS (GROUP) CO., LTD. Stock BTG Hotels (Group) Co., Ltd.
-5.44% 2.28B
MANDARIN ORIENTAL INTERNATIONAL LIMITED Stock Mandarin Oriental International Limited
+7.69% 2.12B
Hotels & Motels
  1. Stock Market
  2. Equities
  3. INDRANIB6 Stock
  4. Financials Indrayani Biotech Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW